Form 8-K - Current report:
SEC Accession No. 0001965040-25-000023
Filing Date
2025-05-12
Accepted
2025-05-12 06:49:09
Documents
15
Period of Report
2025-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ftre-20250512.htm   iXBRL 8-K 26099
2 EX-99.1 exhibit991-pressreleasedat.htm EX-99.1 175795
6 fortrealogo.gif GRAPHIC 2664
  Complete submission text file 0001965040-25-000023.txt   344168

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ftre-20250512.xsd EX-101.SCH 1770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ftre-20250512_lab.xml EX-101.LAB 21611
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ftre-20250512_pre.xml EX-101.PRE 12500
17 EXTRACTED XBRL INSTANCE DOCUMENT ftre-20250512_htm.xml XML 2697
Mailing Address 8 MOORE DRIVE DURHAM NC 27709
Business Address 8 MOORE DRIVE DURHAM NC 27709 877-495-0816
Fortrea Holdings Inc. (Filer) CIK: 0001965040 (see all company filings)

EIN.: 922796441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41704 | Film No.: 25932520
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)